PFOS (perfluorooctanesulfonic acid) and perfluorooctanoic acid (PFOA) are the most concerning PFAS chemicals frequently associated with thyroid disorders. Both are typically present in older formulations of Aqueous Film-Forming Foam (AFFF).
In 2023, researchers at the Mount Sinai Health System published a study, revealing that individuals have a 56% increased risk of being diagnosed with thyroid cancer per doubling of linear perfluorooctanesulfonic acid (n-PFOS) exposure.
Likewise, exposure to PFOA, a well-known endocrine disruptor, may cause hypothyroidism, wherein the thyroid produces insufficient hormones. PFOA may reduce thyrostimulating hormone (TSH) and increase thyroxine (T4) and triiodothyronine (T3) levels. Additionally, it may interfere with NIS (Sodium/Iodide Symporter) and reduce iodine uptake capacity. Both mechanisms are essential for normal hormone production.
There are over 12,000 types of PFAS chemicals. Aside from PFOA and PFAS, other PFAS compounds, such as PFHxS, PFNA, PFDA, PFBA, and PFPA, have also been associated with thyroid-related diseases, albeit to a lesser extent.
If you or a loved one has suffered from thyroid disorders as a consequence of PFAS exposure, we encourage you to call us today. You could be entitled to compensation, and we can guide you on how to proceed.
With more than 35 years of experience, Atraxia Law has assisted countless individuals in submitting their claims for toxic exposure, including those relating to PFAS. Our experts are ready to provide you with assistance and connect you with a qualified lawyer. Schedule an appointment with us today.